Navigation Links
Government Hospitals in Ecuador Continue to Invest in Integrity Life Sciences Technology
Date:12/13/2012

TAMPA, Fla., Dec. 13, 2012 /PRNewswire-iReach/ -- Integrity Life Sciences, a medical device manufacturer based in Tampa, Florida, has announced that it has secured additional contracts further expanding its presence within Government funded hospitals in Ecuador.  This expansion is very welcomed news for Ecuadorians suffering from chronic disc related conditions including herniated disk, sciatica, posterior facet syndrome and degenerative disc disease.

(Photo: http://photos.prnewswire.com/prnh/20121213/CG29463)

Integrity's forward thinking distributor, Omnimed S.A., headquartered in Guayquil, continues to promote the benefits of Non-Surgical Spinal Decompression (NSSD) treatments throughout Ecuador.  Clinicians and patients alike have become highly receptive to the non-invasive alternative for chronic low back and neck pain sufferers. 

Through ongoing training both in Ecuador and at Integrity's Florida manufacturing facility, Omnimed has demonstrated its commitment to the entire healthcare community.  Local representatives will complete a training curriculum that will allow them to serve as in-country technicians and system trainers. 

According to Enzo Pardo, Integrity's international sales representative, "continued expansion in Ecuador, coupled with the incredible response we are receiving from our other South and Central American partners, represents a significant demand for alternative and non-surgical solutions for tens of thousands people negatively impacted by chronic lumbar or cervical pain. What's more, our partner in Ecuador, Omnimed, shares our belief that Integrity's NSSD systems will continue to change the way healthcare providers approach the treatment of disc related issues."  Mr. Pardo went on to say, "we now have multiple unit sales in Ecuador and we have established ourselves as the leader in that particular market segment. It is always nice to see repeat sales to clients. Repeat sales validate the medical protocols, the treatment outcomes and the quality of our equipment"

Integrity Life Sciences delivers a multitude of orthotic treatment options to address one of the most costly systemic ailments in the world, chronic low back and neck pain.  The advanced solution begins with the Integrity Spinal Care System (ISCS 2.0) and theLombare System. Both medical devices are non-surgical spinal decompression therapy systems engineered to provide pain relief for compressive and degenerative conditions of the spine. Specifically, conditions that may be treated include: neck pain and back pain associated with herniated discs, protruding discs, degenerative disc disease, posterior facet syndrome, and sciatica. It achieves these effects through decompression of intervertebral discs, that is, unloading due to distraction and positioning.

Additionally, Integrity offers the very effective Integrity Gel Support Brace. The Integrity Gel Support Brace is a lumbar support brace that is a fitting compliment to non-surgical spinal decompression. The Integrity Gel Support Brace was designed as an adjunct therapy for those suffering from back pain and with the back pain sufferer's needs in mind. The Integrity Gel Support Brace can be used with or without Integrity's non-surgical spinal decompression medical devices, and is an excellent treatment option for personal home use.

Integrity Life Sciences manufactures its products with quality and safety standards as demonstrated by its ISO 13485 registered quality system with TUV SUD and the CE mark affixed to its product.  Our FDA clearance together with compliance to global harmonized standards of both Mark CE and ISO 13485 allows Integrity Life Sciences to distribute to countries all over the world.  As the owner of multiple US Patents, Integrity Life Sciences is committed to ongoing research and development in support of the worldwide healthcare community. Integrity Life Sciences is a privately held USA based company with international partners located across the globe with a mission of "Restoring Integrity to the Spine". For additional information please visit: www.IntegrityLifeSciences.com. To schedule an interview please contact: James Gibson, President & CEO at: telephone: 001-813-935-5500 or email: James@IntegrityLifeSciences.com.

Media Contact: James Gibson Integrity Life Sciences, LLC, 813-935-5500, james@integritylifesciences.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Integrity Life Sciences, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Northwest Bio Awarded $5.5 Million German Government Grant
2. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
3. Remote Patient Monitoring Devices Market to 2017 - Chronic Disease Prevalence and Government Curbs on Hospital Spending to Drive the Market
4. Government Affairs Groups Play Critical Role in Protecting Organizations in Turbulent Times
5. French Government Agrees to Fund Study of the PneumRx RePneu Lung Volume Reduction Coil
6. Patient Monitoring Devices Market in Emerging Countries (China, India, Brazil) to 2017 - Increasing Government Spending and Foreign Direct Investment (FDI) to Drive Future Growth
7. Elusys Awarded Additional $14.5 Million Under Existing U.S. Government Contracts Supporting Expanded Human Safety Studies of ETI-204 for Treatment of Inhalational Anthrax
8. MedicareBlue Rx Drug Plan Earns Federal Governments Top Rating
9. Medical Devices Market in China to 2018 - Government Reforms Aimed at Strengthening the Healthcare System and Expanding Access will Accelerate Growth
10. Government Investments in Upgrades Sustain Laboratory Analytical Instrumentation Market in China, Finds Frost & Sullivan
11. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Australia Glaucoma Surgery Devices Market Outlook ... "Australia Glaucoma Surgery Devices Market Outlook to 2022", ... Surgery Devices market. The report provides value, in ... average prices (USD) within market segement - Glaucoma ... shares and distribution shares data for each of ...
(Date:12/8/2016)... 2016 KEY FINDINGS North ... the market in 2016 and is expected to continue ... to a large number of surgical procedures that are ... share in the patient temperature management market.) Patient warming ... loss of blood during surgeries, lowering the risks of ...
(Date:12/8/2016)... Dec 8, 2016 Research and Markets has ... and Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Electrodes Market is poised to grow at a CAGR of around ... the market is witnessing include advancements in extracellular microelectrode arrays and ...
Breaking Medicine Technology:
(Date:12/10/2016)... ... December 10, 2016 , ... When faced with having to use ... from the seat to her body, and contamination of children when they use public ... solve this problem that many people face. , The patent-pending SANI-POCKET enables a person ...
(Date:12/9/2016)... ... , ... "I have gout, and I wanted to treat it naturally," said ... to relieve gout and pain caused by varicose veins. I drank it every morning ... relieved what VA doctors called the worst sinusitis case they'd seen and relieved gas, ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... The Pierre Hotel in New York, NY, on December 3rd, to benefit Holy ... physicians attended the annual event, which raised over $1 million - the largest ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Florida Hospital ... and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. This accreditation ... a few hospitals and facilities have earned this distinction. This is the second ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
Breaking Medicine News(10 mins):